Amoxicillin Tablet, Coated
Product Images NDC 50090-5863

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 50090-5863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Amoxicillin Tablets Usp 875 mg 1)

A dosing recommendation table for Amoxicillin tablets, coated, for adults and pediatric patients older than 3 months. It details infection types, severity, usual adult doses, and usual pediatric doses per body weight. The table includes notes on dosing guidelines and specific considerations for children under 2 years with probenecid use.*

FDA Label Image

Structural Image (Amoxicillin Tablets Usp 875 mg 2)

Chemical structure diagram of the active ingredient amoxicillin trihydrate, showing its molecular arrangement including the beta-lactam ring, amino group, and phenol group.*

FDA Label Image

Table 3 (Amoxicillin Tablets Usp 875 mg 3)

A data table titled 'Mean Pharmacokinetic Parameters of Amoxicillin (400 mg chewable tablets and 400 mg/5 mL suspension) in Healthy Adults'. It presents pharmacokinetic parameters (AUC and Cmax) for two forms of amoxicillin doses: 400 mg as 5 mL suspension and 400 mg as 1 chewable tablet, along with notes about administration and volunteer sample size.*

FDA Label Image

Bacteria (Amoxicillin Tablets Usp 875 mg 4)

A data table listing various bacteria categorized as Gram-Positive and Gram-Negative. Gram-Positive bacteria include Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci. Gram-Negative bacteria include Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori.*

FDA Label Image

Table 6 (Amoxicillin Tablets Usp 875 mg 5)

A data table titled 'H. pylori Eradication Rates When Amoxicillin is Administered as Part of a Triple Therapy Regimen' comparing eradication rates from two studies. It presents Triple Therapy outcomes using evaluable analysis and intent-to-treat analysis, including percentage eradication rates, 95% confidence intervals, and patient numbers for each study. Footnotes explain analysis criteria related to duodenal ulcer and H. pylori infection confirmation.*

FDA Label Image

Table 7 (Amoxicillin Tablets Usp 875 mg 6)

A data table titled 'H. pylori Eradication Rates When Amoxicillin is Administered as Part of a Dual Therapy Regimen' showing eradication percentages and 95% confidence intervals for two studies. The table compares evaluable analysis and intent-to-treat analysis groups with patient counts indicated. Footnotes explain criteria for patient inclusion and handling of dropouts in the analyses.*

FDA Label Image

Label Image (Lbl500905863)

Amoxicillin 875 mg coated tablets label from A-S Medication Solutions. The label states each film-coated tablet contains amoxicillin trihydrate equivalent to 875 mg amoxicillin. Storage instructions advise keeping at 68 to 77 degrees Fahrenheit, protected from light and moisture. The package contains 20 tablets and includes dosage and package insert information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.